All News

The FDA released a recent statement explaining that it is now recommending all pharmacists discuss naloxone with patients when prescribing opioid pain relievers or medicines to treat opioid use disorder (OUD).

Although the rapid expansion of telehealth has been an essential part of keeping patients safe during the COVID-19 pandemic, the potential long-term effects of this expansion have not been fully understood.

An expert panel of world-renowned professionals will discuss the latest details on the rapid advances in vaccine development and what they mean to clinicians on the front line.

As legislators debate the next stimulus package, pharmacists are expressing dismay that the current language does not include designating pharmacists as providers under Medicare Part B for COVID-19 testing and immunization.

Individuals covered via high-deductible health care plans not found to have a greater risk of heart attack or stroke.

Plant-based diets rich in whole carbohydrates may help improve type 1 diabetes.

A new study found that it’s safe for patients with HIV to receive HIV-positive kidneys.

The results of a level 1 trauma center study have shown that ibuprofen injection (Caldolor, Cumberland Pharmaceuticals) significantly reduces the quantity of opioids required to manage pain after a traumatic injury with fracture.

Juven, a therapeutic wound healing drink from Abbott, has hit the shelves of CVS Pharmacy locations, according to a press release.

Both premenopausal and postmenopausal breast cancer rates are rising globally.

Evidence suggests that individuals who have more severe COVID-19 illness requiring hospitalization may still have symptoms that persist even after recovery from infection.

The project aims to demonstrate the value of collaboration between pharmacists and health care payers in the delivery of patient-centered care.

Pharmacy Times spoke with Ron Lanton, Principal at Lanton Law, about Rutledge v. PCMA and its impact on pharmacy and PBMs.

Although the treatment of cancer is facing many challenges, the pandemic is also creating massive amounts of new data with which to educate patients, conduct new research, and make more informed clinical decisions.

New research suggests vitamin D can help prevent colitis in those using immune checkpoint inhibitors.

Working memory development plateaus in the mid-to-late teens and can begin to decline after age 40.